<p>Some experts express concern about ‘lack of transparency’ as agency removes warnings on three estrogen patches</p><p>Three more patches for treating menopause will no longer carry black-box warnings about cardiovascular disease, breast cancer, and dementia, officials at the US Food and Drug Administration (FDA) said on Friday.</p><p>The FDA did not convene an advisory committee and offered few details on the scientific basis for the decision in the press briefing. The news follows the removal of black-box warnings from six menopause treatments in February, as patients across the US struggle with shortages of the patches.</p> <a href="https://www.theguardian.com/us-news/2026/oct/30/fda-remove-warnings-menopause-treatments">Continue reading...</a>
World
FDA again bypasses advisers to remove black-box warnings from menopause treatments
<p>Some experts express concern about ‘lack of transparency’ as agency removes warnings on three estrogen patches</p><p>Three more patches for treating menopause will no longer carry black-box warnings about cardiovascular disease, breast cancer, and dementia, officials at the US Food and Drug Administration (FDA) said on Friday.</p><p>The FDA did not convene an advisory committee and offered few details on the scientific basis for the decision in the press briefing. The news follows the removal of black-box warnings from six menopause treatments in February, as patients across the US struggle with shortages of the patches.</p> <a href="https://www.theguardian.com/us-news/2026/oct/30/fda-remove-warnings-menopause-treatments">Continue reading...</a>